Stay updated on NiCOL: Nivolumab Combo in Advanced Cervical Cancers Clinical Trial
Sign up to get notified when there's something new on the NiCOL: Nivolumab Combo in Advanced Cervical Cancers Clinical Trial page.

Latest updates to the NiCOL: Nivolumab Combo in Advanced Cervical Cancers Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has been updated to reflect a new version of the study, with the addition of 'Cervical Cancer' and 'Collaborators Bristol-Myers Squibb', while significant details about the study's aim and inclusion/exclusion criteria have been removed.SummaryDifference26%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check79 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check87 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to NiCOL: Nivolumab Combo in Advanced Cervical Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NiCOL: Nivolumab Combo in Advanced Cervical Cancers Clinical Trial page.